Avalo Therapeutics (AVTX) Earnings Date & Reports

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

AVTX is expected to report earnings to fall 32.72% to -55 cents per share on November 05

Avalo Therapeutics AVTX Stock Earnings Reports

Q3'26

Est.

$-0.56

Q2'26

Missed

by $0.25

Q1'26

Beat

by $0.78

Q4'25

Beat

by $0.50

Q3'25

Missed

by $0.97

The last earnings report on August 06 showed earnings per share of -82 cents, missing the estimate of -57 cents. With 333.36K shares outstanding, the current market capitalization sits at 1.06B.

View a ticker or compare two or three

AVTX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days